Cardiff Oncology, Inc. Common Stock (CRDF) is a publicly traded Healthcare sector company. As of July 15, 2026, CRDF trades at $0.85 with a market cap of $92.30M and a P/E ratio of -1.45. CRDF moved -35.11% today. Year to date, CRDF is -53.38%; over the trailing twelve months it is -68.28%. Its 52-week range spans $1.16 to $5.64. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces CRDF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CRDF combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.85 |
| Market Cap | $92.30M |
| P/E Ratio | -1.45 |
| EPS | $-0.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.64 |
| 52-Week Low | $1.16 |
| Volume | 9.17M |
| Avg Volume | 0 |
| Revenue (TTM) | $488.00K |
| Net Income | $-41.44M |
| Gross Margin | 0.00% |
7 analysts cover CRDF: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.